170 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
SCIENTIFIC PROGRAMME
162
002
Activation of microglia in an animal model of
schizophrenia
Georg Juckel, Germany
003
Transcriptional regulation of synapse density
in autism and intellectual disability
Christopher W. Cowan, USA
Adam Harrington, Ahlem Assali, Carly Hale, Kimberly
Huber, Aram Raissi
004
Bipolar disorder-like cycling of behavior
induced by D1 receptor manipulation
Nadja Freund, Germany
S-212
Symposium
17:00– 18:30
|
Room Lindau 3
TOPIC 23:
Health care research and models, health care
policy
Whose experience, whose research, whose benefit?
On participation, co-production, and user-leadership
in mental health research
Chairs:
Elena Demke, Germany
Sebastian von Peter, Germany
001
Perspective, power and partnership: challeng-
ing methodological assumptions in a coproduced,
randomised controlled trial of peer support
Sarah Gibson, United Kingdom
Steve Gillard
002
Co-production in mad studies research and
teaching
Jijan Voronka, Canada
Kathryn Church
003
Scientist-users redesign psychiatry: bridging
the science-to-service gap by building experiential
knowledge
Wilma Boevink, The Netherlands
S-213
Symposium
17:00– 18:30
|
Hall New York 3
TOPIC 16:
Diagnostics and classification,
psychopathology, RDoC
Contemporary issues in the assessment of psycho-
pathology
›
WPA Section: Measurement Instruments in Psychiatric
Care
Chairs:
Vladan Starcevic, Australia
Aleksandar Janca, Australia
001
Short diagnostic instruments for anxiety disor-
ders: are they good enough?
Milan Latas, Serbia
002
Culture and assessment of psychopathology:
a focus on Australian Aboriginal people
Aleksandar Janca, Australia
003
Dimensional and categorical assessment of
personality disorders: advantages and disadvantages
Peter Tyrer, United Kingdom
004
Assessment of transdiagnostic constructs: how
helpful are worry, intolerance of uncertainty and
dysphoria?
Vladan Starcevic, Australia
S-055 (d)
Symposium (German)
17:00– 18:30
|
Hall A1
TOPIC 7:
Personality disorders
Trialogischer Austausch über die Therapie der
Borderline-Störung: was nutzt, was schadet?
Chairs:
Anja Link, Germany
Martin Bohus, Germany
001
Borderline in der Familie – die Sicht einer Mutter
Doris, Germany
002
Borderline in der Familie – die Sicht eines Vaters
Volker, Germany
003
Die Sicht einer Borderline-Betroffenen
Johanna Micksch, Germany
S-056 (d)
Symposium (German)
17:00– 18:30
|
Hall A2
TOPIC 20:
Prevention and health promotion
Resilienz – eine neue Chance für Prävention und
Intervention
Chairs:
Klaus Lieb, Germany
Franz-Josef Wagner, Germany
001
Psychologische und neurobiologische Resilienz-
mechanismen – das Gehirn als Resilienzorgan
Oliver Tüscher, Germany
Marianne B. Müller, Raffael Kalisch
002
Eine systematische Übersicht über wirksame
Programme zur Resilienz-Förderung
Angela Kunzler, Germany
Isabella Helmreich, Andrea Chmitorz, Jochem König,
Harald Binder, Michèle Wessa, Klaus Lieb
003
Wege zur Resilienz in der Region Pfalz
Paul Bomke, Germany
004
Resilienz und Recovery aus der Sicht eines
Betroffenen
Franz-Josef Wagner, Germany